GMO Beyond China ETF (NYSEARCA:BCHI) Sees Significant Decrease in Short Interest

GMO Beyond China ETF (NYSEARCA:BCHI) was the target of a significant drop in short interest in the month of February. As of February 27th, there was short interest totaling 6,281 shares, a drop of 78.1% from the February 12th total of 28,674 shares. Approximately 1.6% of the shares of the stock are sold short. Based on an average trading volume of 2,101 shares, the days-to-cover ratio is currently 3.0 days. Based on an average trading volume of 2,101 shares, the days-to-cover ratio is currently 3.0 days. Approximately 1.6% of the shares of the stock are sold short.

GMO Beyond China ETF Stock Up 0.5%

BCHI stock traded up $0.16 during mid-day trading on Wednesday, hitting $32.86. The company had a trading volume of 347 shares, compared to its average volume of 4,139. The company has a 50-day moving average price of $33.06 and a 200 day moving average price of $30.90. GMO Beyond China ETF has a 12-month low of $21.81 and a 12-month high of $35.86. The company has a market capitalization of $13.14 million, a price-to-earnings ratio of 14.75 and a beta of 1.37.

Institutional Investors Weigh In On GMO Beyond China ETF

An institutional investor recently bought a new position in GMO Beyond China ETF stock. Lazard Asset Management LLC bought a new position in GMO Beyond China ETF (NYSEARCA:BCHI) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 20,851 shares of the company’s stock, valued at approximately $570,000. Lazard Asset Management LLC owned about 5.21% of GMO Beyond China ETF at the end of the most recent quarter.

About GMO Beyond China ETF

The GMO Beyond China ETF (BCHI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed to invest in equity securities of any market capitalization from emerging markets, with the exemption of China. BCHI was launched on Feb 12, 2025 and is issued by GMO.